NEW YORK (Reuters Health) – While oxybutynin is often used prophylactically to reduce irritative urinary symptoms related to intravesical bacillus Calmette-Guerin (BCG) therapy for bladder cancer, it actually…
NEW YORK (Reuters Health) – Complete bladder neck preservation during radical prostatectomy improves the rate of urinary continence subsequently, a German team reports. Furthermore, the strategy is associated…
NEW YORK (Reuters Health) – Intravesical bacille Calmette-Guérin (BCG) therapy for bladder cancer is associated with eradication of uropathogens in patients not taking antibiotics, according to a new…
NEW YORK (Reuters Health) – Compared to white light cystoscopy, hexaminolevulinate fluorescence cystoscopic detection of papillary, nonmuscle invasive bladder cancer appears superior, researchers report in a May 12th…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
